NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]

 Lurati A, Bertani L, Marrazza M, Re KA, Bompane D, Scarpellini M. Biologics: Targets and Therapy. 2012;6:83–87.On page 87, the disclosure was listed as ‘The authors report no conflicts of interest in this work.’ in error. The correct disclosure should be &...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lurati A, Bertani L, Marrazza M, Re KA, Bompane D, Scarpellini M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/6c19b83cc3b545b9a8110932db342558
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6c19b83cc3b545b9a8110932db342558
record_format	dspace
spelling	oai:doaj.org-article:6c19b83cc3b545b9a8110932db3425582021-12-02T06:17:54ZNK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]1177-54751177-5491https://doaj.org/article/6c19b83cc3b545b9a8110932db3425582013-12-01T00:00:00Zhttp://www.dovepress.com/corrigendum-nk-cell-count-as-predictor-of-clinical-response-in-pa-a15198https://doaj.org/toc/1177-5475https://doaj.org/toc/1177-5491 Lurati A, Bertani L, Marrazza M, Re KA, Bompane D, Scarpellini M. Biologics: Targets and Therapy. 2012;6:83–87.On page 87, the disclosure was listed as ‘The authors report no conflicts of interest in this work.’ in error. The correct disclosure should be ‘An unrestricted publication grant was provided by Roche S.p.A. The authors have no other conflicts of interest to report.’Read the original articleLurati ABertani LMarrazza MRe KABompane DScarpellini MDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2013, Iss default, Pp 265-266 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Lurati A Bertani L Marrazza M Re KA Bompane D Scarpellini M NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
description	Lurati A, Bertani L, Marrazza M, Re KA, Bompane D, Scarpellini M. Biologics: Targets and Therapy. 2012;6:83–87.On page 87, the disclosure was listed as ‘The authors report no conflicts of interest in this work.’ in error. The correct disclosure should be ‘An unrestricted publication grant was provided by Roche S.p.A. The authors have no other conflicts of interest to report.’Read the original article
format	article
author	Lurati A Bertani L Marrazza M Re KA Bompane D Scarpellini M
author_facet	Lurati A Bertani L Marrazza M Re KA Bompane D Scarpellini M
author_sort	Lurati A
title	NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
title_short	NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
title_full	NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
title_fullStr	NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
title_full_unstemmed	NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
title_sort	nk cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [corrigendum]
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/6c19b83cc3b545b9a8110932db342558
work_keys_str_mv	AT luratia nkcellcountaspredictorofclinicalresponseinpatientswithrheumatoidarthritistreatedwithrituximabcorrigendum AT bertanil nkcellcountaspredictorofclinicalresponseinpatientswithrheumatoidarthritistreatedwithrituximabcorrigendum AT marrazzam nkcellcountaspredictorofclinicalresponseinpatientswithrheumatoidarthritistreatedwithrituximabcorrigendum AT reka nkcellcountaspredictorofclinicalresponseinpatientswithrheumatoidarthritistreatedwithrituximabcorrigendum AT bompaned nkcellcountaspredictorofclinicalresponseinpatientswithrheumatoidarthritistreatedwithrituximabcorrigendum AT scarpellinim nkcellcountaspredictorofclinicalresponseinpatientswithrheumatoidarthritistreatedwithrituximabcorrigendum
_version_	1718399996901982208

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]

Ejemplares similares